Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7789]

Provectus outlines path forward for PV-10

Provectus outlines path forward for PV-10

Immune cells found near tumours boost breast cancer survival

Immune cells found near tumours boost breast cancer survival

Advances in personalised medicine

Advances in personalised medicine

Pooled analysis of two phase III trials shows eribulin improves survival in advanced breast cancer

Pooled analysis of two phase III trials shows eribulin improves survival in advanced breast cancer

ASCO 2014: PD-1 targeting immunotherapy MK-3475 has high and long-lasting activity against metastatic melanoma

ASCO 2014: PD-1 targeting immunotherapy MK-3475 has high and long-lasting activity against metastatic melanoma

ASCO 2014: Ipilimumab with nivolumab achieves long-term survival in advanced melanoma

ASCO 2014: Ipilimumab with nivolumab achieves long-term survival in advanced melanoma

ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014: Adjuvant ipilimumab improves recurrence-free survival in high-risk melanoma

ASCO 2014: Adjuvant ipilimumab improves recurrence-free survival in high-risk melanoma

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in...

ASCO 2014: Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer

ASCO 2014: Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone...

More from ecancer